Steatohepatitis
Mostrando 13-24 de 64 artigos, teses e dissertações.
-
13. Non-alcoholic steatohepatitis-related liver cirrhosis is increasing in China: A ten-year retrospective study
OBJECTIVE:Little is known about metabolic factors in cirrhotic patients in China. Therefore, we aimed to quantify the prevalence of both metabolic factors and non-alcoholic steatohepatitis-related liver cirrhosis in China.METHODS:The medical records of 1,582 patients diagnosed with liver cirrhosis from June 2003 to July 2013 at Daping Hospital (Chongqing, Ch
Clinics. Publicado em: 2015-08
-
14. Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model
Liver fibrosis occurring as an outcome of non-alcoholic steatohepatitis (NASH) can precede the development of cirrhosis. We investigated the effects of sorafenib in preventing liver fibrosis in a rodent model of NASH. Adult Sprague-Dawley rats were fed a choline-deficient high-fat diet and exposed to diethylnitrosamine for 6 weeks. The NASH group (n=10) rece
Braz J Med Biol Res. Publicado em: 24/02/2015
-
15. Hepatitis virus and hepatocellular carcinoma in Brazil: a report from the State of Espírito Santo
IntroductionFew studies have examined hepatocellular carcinoma (HCC) in Brazil, and the incidence and risk factors for this type of malignancy vary greatly geographically. In this paper, we report several risk factors associated with HCC diagnosed at the University Hospital in Vitória, ES, Brazil.MethodsWe reviewed 274 cases of HCC (January 1993 to December
Rev. Soc. Bras. Med. Trop.. Publicado em: 2014-10
-
16. The spectrum of non alcoholic fatty liver disease in morbidly obese patients: prevalence and associate risk factors
PURPOSE: To determine the prevalence of non alcoholic fatty liver disease (NAFLD) and non alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery and to identify risk factors associated with the disease spectrum. METHODS: Liver biopsy was performed in 60 patients who underwent bariatric surgery, after other causes of liver di
Acta Cir. Bras.. Publicado em: 2013-11
-
17. O papel da ultrassonografia na medida da gordura subcutânea e visceral e sua correlação com a esteatose hepática
Objective To evaluate the sonographic measurement of subcutaneous and visceral fat in correlation with the grade of hepatic steatosis. Materials and Methods In the period from October 2012 to January 2013, 365 patients were evaluated. The subcutaneous and visceral fat thicknesses were measured with a convex, 3–4 MHz transducer transversely placed 1 cm abo
Radiol Bras. Publicado em: 2013-10
-
18. Diabetes mellitus triggers oxidative stress in the liver of alloxan-treated rats: a mechanism for diabetic chronic liver disease
PURPOSE: To investigate whether Diabetes mellitus chemically induced by alloxan is capable of changing, in the long term, the oxidative balance in the liver tissue of rats. METHODS: Sixty male Wistar rats, weighing 250-280g, were randomly distributed into two experimental groups: NG - 30 non-diabetic control rats; DG - 30 alloxan- induced diabetic rats witho
Acta Cir. Bras.. Publicado em: 2013-07
-
19. Efeito dos ácidos graxos saturados, poli-insaturados e trans no desenvolvimento de aterosclerose e esteatose hepática em camundongos com ablação gênica do receptor de LDL / Effect of saturated, polyunsaturated and trans fatty acids on the development of atherosclerosis and hepatic steatosis of mice with ablation of the LDL receptor gene
Introduction: The amount and type of dietary fat play important roles on the development of cardiovascular disease (CVD) and on the development of hepatic steatosis. Saturated (SAT) and trans (TRANS) fatty acids are known as pro-atherogenic, while the polyunsaturated (POLY) fats seem to exert an antiatherogenic action. Regarding hepatic steatosis, it is know
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 18/12/2012
-
20. Modelo experimental para indução de esteatose hepática e esteatohepatite: estudo em ratos / Experimental model for induction of steatosis and steatohepatitis - study in rats
Introdução: A Doença Hepática Gordurosa Não Alcoólica (DHGNA) tem sido considerada atualmente a forma mais comum de doença hepática no mundo ocidental, relacionada principalmente ao aumento da prevalência da obesidade.A DHGNA abrange um largo espectro de doença, desde casos de esteatose simples (EH) até esteato-hepatite não alcoólica (EHNA) e fi
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 29/10/2012
-
21. Alopurinol na prevenção da esteato-hepatite não alcoólica e hiperglicemia induzida por dieta rica em frutose em ratos wistar
Nonalcoholic fatty liver disease (NAFLD) in the last two decades has been recognized as the most common chronic liver disease in Western countries, paralleling the epidemic of obesity and consumption of high-fructose diet. Researchers suggest that NAFLD may be the hepatic manifestation of metabolic syndrome. Although NAFLD and hyperuricemia are strongly rela
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 27/03/2012
-
22. Síndrome metabólica e fatores de risco para a doença hepática gordurosa não-alcoólica
CONTEXTO: A doença hepática gordurosa não alcoólica (DHGNA) vem sendo considerada a manifestação hepática da síndrome metabólica e a hepatopatia mais frequente da atualidade, sendo também a causa mais frequente de aumento das transaminases e de cirrose criptogênica. O maior aporte de ácidos graxos ao fígado e consequente aumento da beta-oxidaç�
Arquivos de Gastroenterologia. Publicado em: 2012-03
-
23. Ação hepatoprotetora do antioxidante quercitina no modelo esperimental de esteato-hepatite não alcoólica
Introduction: Non-alcoholic steatohepatitis is a disease with a high incidence, difficult diagnosis, and yet no effective treatment. This reasons lead to the use of experimental models for induction of NASH, and the study of routes developing this disease, as well as attempts to a effective therapy. Aims: This study was designed to develop an experimental mo
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 2012
-
24. Consumo Alimentar dos Portadores de Doença Hepática Gordurosa Não Alcoólica: Comparação entre a Presença e Ausência de Síndrome Metabólica e a Gravidade da Doença / Food Intake of Patients with Nonalcoholic Fatty Liver Disease: Comparison between the presence and absence of Metabolic Syndrome and Severity of Disease
Purpose: To evaluate the dietary intake of subjects with nonalcoholic fatty liver disease (NAFLD) and compare with recommended dietary intake, presence and absence of metabolic syndrome (MS) and disease severity (presence and absence of nonalcoholic steatohepatitis). Methods: We first evaluated 158 patients with a diagnosis of NAFLD by clinical examination,
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 25/05/2011